Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $279,549 | $249,500 | $204,986 |
| - Cash | $8,933 | $26,309 | $29,021 | $46,074 |
| + Debt | $201,957 | $202,833 | $202,787 | $202,882 |
| Enterprise Value | – | $456,073 | $423,266 | $361,794 |
| Revenue | $13,294 | $11,489 | $9,889 | $9,379 |
| % Growth | 15.7% | 16.2% | 5.4% | – |
| Gross Profit | $13,294 | $11,489 | $9,889 | $9,379 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$45,467 | -$35,316 | -$33,550 | -$31,626 |
| % Margin | -342% | -307.4% | -339.3% | -337.2% |
| Net Income | -$48,221 | -$38,273 | -$36,638 | -$33,029 |
| % Margin | -362.7% | -333.1% | -370.5% | -352.2% |
| EPS Diluted | -0.21 | -0.17 | -0.16 | -0.15 |
| % Growth | -23.5% | -6.3% | -6.7% | – |
| Operating Cash Flow | -$36,167 | -$47,061 | -$39,724 | -$35,481 |
| Capital Expenditures | $0 | -$53 | -$26 | $0 |
| Free Cash Flow | -$36,167 | -$47,114 | -$39,750 | -$35,481 |